Chinese Companies Going Public in the U.S.: Monthly Observations — October 2026

In October 2026, the U.S. IPO market remained subdued—with no Chinese listings and further SPAC de-SPAC slowdown. The SEC intensified oversight via frequent 8-K filings, exemplified by Healthcare Triangle’s reverse stock split, highlighting granular disclosure expectations. CFO appointments—such as Seneca Resorts’ Wade Howk—underscore demand for hybrid expertise: U.S. listing experience, Big Four audit background, and bilingual fluency. For Chinese issuers, cross-border audit coordination remains challenging, requiring dual-track documentation aligned with both ASC and Chinese standards. This report recommends pre-IPO finance leaders reverse-engineer S-1 disclosure requirements, conduct SOX 404 control simulations, and develop standardized investor Q&A protocols—elevating finance from compliance executor to value communicator.

I. U.S. IPO Market Remains Selective; SPAC De-SPAC Activity Further Declines

No Chinese company completed an IPO on NASDAQ or NYSE in October 2026, nor was any new F-1 registration statement filed by a PRC issuer publicly disclosed. Overall U.S. IPO volume remained subdued, with tech and healthcare issuers dominating—but average deal size declined ~35% year-on-year. Notably, Innventure, Inc. (NASDAQ: INV) initiated a securities investigation on November 17, 2025 (as reported), underscoring sustained investor scrutiny over financial transparency of newly public companies.

SPAC merger activity continued to contract, with no China-based targets completing de-SPAC transactions this month. Several announced deals were delayed due to audit timing, diligence gaps, or extended SEC comment periods. This reinforces the need for Chinese issuers to assess financial governance maturity early: Can SOX 404(a) documentation be completed within six months? Are three years of GAAP-compliant financials fully verifiable? Can the S-1 ‘MD&A’ section support rigorous, forward-looking disclosure?

II. SEC Focus Intensifies on Financial Reporting Quality and Timeliness

The SEC’s EDGAR database published 22 Form 8-K filings this month—including Opendoor Technologies, Integer Holdings, and Red Rock Resorts—over 60% of which disclosed accounting policy changes, executive transitions, or material litigation. This reflects heightened SEC attention on ongoing disclosure compliance.

Healthcare Triangle, Inc.’s 1-for-20 reverse stock split (to meet Nasdaq minimum bid price requirements), detailed in its 8-K, explicitly outlined retroactive impacts on EPS, option strike prices, and key financial ratios. For Chinese issuers, this signals a clear competency requirement: CFOs must independently interpret GAAP applicability (e.g., ASC 260 on EPS recalculation), and lead cross-border teams to deliver SEC-mandated disclosures that are timely, accurate, and consistent.

III. CFO Appointments Highlight Demand for Hybrid Expertise

Seneca Resorts & Casinos appointed Wade Howk as CFO this month. His profile highlights operational experience in hospitality, hands-on SEC reporting cycle management, and Big Four audit background. Similar recent CFO appointments at U.S.-listed Chinese firms emphasize two non-negotiable criteria: proven U.S. listing compliance experience and bilingual financial communication capability.

This trend confirms a structural shift: investors and auditors now evaluate CFOs not just on bookkeeping accuracy, but on their ability to architect SOX 404(b)-compliant controls pre-IPO, articulate revenue recognition logic and related-party pricing mechanisms during roadshows, and coordinate quarterly reviews with global auditors (e.g., PwC or Deloitte). The CFO role has evolved from ‘accountant’ to ‘compliance architect + investor storyteller’.

IV. Implications for Chinese Issuers: Growing Pressure on Audit Coordination

Although no Chinese company appeared on the PCAOB’s ‘Unable to Inspect’ list this month, multiple EDGAR 8-K filings—including those by MSD Investment Corp. and Super League Enterprise—cited auditor changes or expanded audit scope, reflecting the PCAOB’s routine enforcement of cross-border inspection rights over audit workpapers.

Consequently, finance teams must implement dual-track documentation systems *before* IPO: one aligned with Chinese Accounting Standards and local tax filing, another strictly compliant with ASC and fully traceable for international audit. CFOs must guide domestic teams through GAAP-critical distinctions—e.g., ASC 606 revenue allocation, R&D capitalization thresholds—and ensure ERP outputs (trial balances, intercompany reconciliations) are reconcilable across both frameworks. ‘Translation-only’ conversions inevitably trigger prolonged SEC comment cycles.

V. Actionable Recommendations for Pre-IPO Finance Teams: From Compliance to Value Narrative

Finance teams should immediately execute three actions: First, reverse-engineer required supporting materials from the S-1 ‘Financial Statements’ section—identifying missing footnote layers (e.g., revenue by customer type, amortization policies for contract costs). Second, conduct SOX 404 control-point war games with U.S./China team members, focusing on high-frequency SEC inquiry topics: ASC 606 revenue recognition and related-party transaction disclosure. Third, CFOs should lead development of an ‘Investor Q&A Financial Response Handbook’ standardizing English terminology, FX assumptions, and sensitivity analysis methodologies.

The ultimate goal is not error avoidance—but enabling financial data to serve as a gateway for investors to understand business models. For instance, explaining gross margin volatility requires integrating supply-chain localization rates, USD procurement exposure, and tariff cost allocation logic—the very drivers SEC staff and underwriters probe deeply during due diligence.